Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
Recent TSHA News
- Taysha Gene Therapies Announces Oral Presentation on TSHA-102 in Rett Syndrome at Upcoming 9th World Rett Syndrome Congress • GlobeNewswire Inc. • 09/26/2024 12:00:00 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/06/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 12:32:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:05:53 PM
- Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/12/2024 12:01:00 PM
- Taysha Gene Therapies to Release Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 12 • GlobeNewswire Inc. • 08/05/2024 12:00:00 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/02/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/05/2024 09:51:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/05/2024 09:50:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/05/2024 09:49:24 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/05/2024 12:00:00 PM
- Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 06/26/2024 01:14:46 PM
- Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 06/25/2024 10:34:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 11:45:05 AM
- Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome • GlobeNewswire Inc. • 06/18/2024 11:30:00 AM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/07/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 08:18:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:02:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:18:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:12:35 PM
- Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/14/2024 08:01:00 PM
- Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14 • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/03/2024 08:05:00 PM
- Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome • GlobeNewswire Inc. • 05/02/2024 12:00:00 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/05/2024 12:00:00 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM